Latest financial market updates and expert analysis
Analysis Pharmaceutical giant Eli Lilly faces a pivotal regulatory milestone in March 2026, with the U.S. Food and Drug Administration (FDA) poised to rule on Orforglipron. This oral GLP-1 weight-loss drug...
A sharp escalation of geopolitical tensions in the Middle East has injected significant volatility into global energy markets, propelling crude...
Nvidia’s latest annual financial performance shattered expectations, posting a net profit exceeding $120 billion. Despite these formidable figures, the company’s...
The payments processing sector presents a challenging landscape, and Adyen NV is navigating it from a position of underlying strength....
Recent developments at Viking Therapeutics have presented market participants with two distinct signals to interpret. While a major institutional investor...
Realty Income Corporation, the prominent real estate investment trust, is navigating a significant leadership transition in its legal department while...
Analysts are reassessing their positions on Adobe, with Barclays becoming the latest to update its view. On Wednesday, the investment...
Energy major Equinor has demonstrated a cost-effective approach to boosting reserves in the North Sea, focusing on incremental gains rather...
A strategic pivot by Almonty Industries (DRC) is positioning the company at the forefront of a significant realignment in the...
Future Fuels is advancing its strategic growth plan within the North American uranium sector through a significant corporate acquisition. The...
The share price of Northern Dynasty Minerals has come under significant pressure following the launch of multiple independent investigations by...
